1、投稿方式：在线投稿。

2、期刊网址：

https://journals.lww.com/ectjournal/pages/default.aspx

3、投稿网址：

https://www.editorialmanager.com/ject/default.aspx

4、官网邮箱：emily.hurd@wolterskluwer.com

5、期刊刊期：季刊，逢季末月出版。

2021年2月23日星期二

投稿须知【官网信息】

Instructions for Authors

Scope

The Journal of ECT is an international journal that aims at a greater understanding of the effects of induced seizures on behavior and organ systems, both in animals and in humans, and of seizures, their mode of induction, their occurrence, and their propagation. The Journal is a forum for original scientific articles, reviews, commentaries, and letters.

The scope of articles may be broad, encompassing anatomic, structural, physiologic, biochemical, psychologic, and neurophysiologic studies of the effects of seizures and of the seizure process itself. Discussions of sociologic, legal, and ethical aspects of research and clinical practice are of interest. The Editors believe that the Journal can make a special contribution to clinical practice by providing a clinical forum for the reporting of both basic and clinical research into the convulsive therapy process. Rapid communications of new information are welcomed.

The journal has limited capacity to assist with correcting problems in written English. Articles submitted to the journal must be written with a solid grasp of the English language. If you need assistance in this area, use of an editorial service is at the discretion and cost of the authors, and will not guarantee acceptance for publication in the journal.

If you need assistance with English, consider visiting a service that can help, such as: http://journals.lww.com/ectjournal/_layouts/1033/oaks.journals/editservices.aspx

Ethical/Legal Considerations

A submitted manuscript must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher. All manuscripts must be submitted on-line through the journal's Web site at http://ject.edmgr.com. See submission instructions on the next page, under "On-line manuscript submission."

Conflicts of Interest

Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:”. For example:

Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.

Copyright: In addition, each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors, "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (www.icmje.org/update.html).

A copy of the form is made available to the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with instructions on completing the form upon submission.

Patient Anonymity and Informed Consent

It is the authors’ responsibility to ensure that patients’ anonymity is carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and followed all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should remove patients' names and other identifying information from figures. If any identifying details appear in text, tables, and/or figures, the author must provide proof of informed consent obtained from the patient (i.e., a signed permissions form). Photographs with bars placed over eyes of patients should NOT be used in publication. If they are used, permission from the patient is required.

Compliance with NIH and Other Research Funding Agency Public Access Requirements

A number of research funding agencies require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, WK will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, or Howard Hughes Medical Institute, to PubMed Central. Authors may indicate such funding when completing the Copyright Transfer Agreement.

Open access

Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. Authors may take advantage of the open access option at the point of acceptance to ensure that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.

The article processing charge (APC) is charged on acceptance of the article and should be paid within 30 days by the author, funding agency or institution. Payment must be processed for the article to be published open access. For a list of journals and pricing please visit our Wolters Kluwer Open Health Journals page.

Authors retain copyright

Authors retain their copyright for all articles they opt to publish open access. Authors grant Wolters Kluwer an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license. Please visit our Open Access Publication Process page for more information.

Creative Commons license

Open access articles are freely available to read, download and share from the time of publication under the terms of the Creative Commons License Attribution-NonCommerical No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission.

Compliance with funder mandated open access policies

An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license is able to meet that requirement through the available open access license for approved funders. Information about the approved funders can be found here: http://www.wkopenhealth.com/inst-fund.php

FAQ for open access

http://www.wkopenhealth.com/openaccessfaq.php

Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.

Manuscript Submission

On-line manuscript submission: All manuscripts must be submitted on-line at http://ject.edmgr.com/. First-time users: Please click the Register button from the menu above and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor). Authors: Please click the log-in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact the Editorial Office: emily.hurd@wolterskluwer.com.

Article Types

The Journal accepts for publication the following types of articles. Please contact the Editorial Office with any questions regarding submission requirements for a specific article type.

Original Study – reports of both basic and clinical research into electroconvulsive therapy and other forms of therapeutic brain stimulation for mental disorders are welcomed. Original Studies should be no more than 5000 words and include the following headings: Introduction, Methods, Results, and Discussion. For all studies reporting animal or human research, the Materials and Methods section must include a statement regarding review board approval and adherence to ethical standards; for human research, this includes a statement regarding informed consent. A structured abstract must be provided.

Case report – Case Reports will be considered for publication as either a regular, full “Case Report” or a more brief “Letter to the Editor”. To be considered as a full Case Report, the submission must include a truly novel case that has the potential to change thinking within the field of therapeutic brain stimulation, and the submission should include a thorough review of the existing literature and explanation of how this case advances the field. Case Reports should be no more than 2000 words, contain a maximum of 5 references, and include an unstructured abstract. The report itself should include the following headings: Introduction, Case Report, and Discussion. In contrast, cases that are less novel or replications of prior reports should be submitted as a Letter to the Editor, with no abstract, no more than 1000 words, no tables or figures, and no more than 5 references. The Editorial Board reserves the right to recommend that cases submitted as 'Case Reports' be revised as Letters to the Editor.

Review Article – Review Articles focusing on various aspects of electroconvulsive therapy and other forms of therapeutic brain stimulation for mental disorders, historical issues of relevance to current practice, or international aspects of the practice are welcomed. Review Articles must be no more than 5000 words and include an unstructured abstract.

Images in Clinical ECT – Images of EEG recordings or of items of clinical interest to practitioners of electroconvulsive therapy and other forms of therapeutic brain stimulation for mental disorders may be submitted for consideration. The image or picture should tell the story; the text must not exceed 500 words. If text >500 words is required, then the article should be submitted as a case report. Articles should be submitted without an abstract.

Commentary – Commentaries may focus on timely issues of interest to the international ECT community. Commentary submissions do not require an abstract.

Letter to the Editor – Letters should focus on articles recently published in the Journal, or may describe brief case reports (see above). In general, letters to the editor should be submitted with no abstract, no more than 1000 words, no tables or figures, and no more than 5 references. If the authors' comments do not directly relate to a recently-published article or describe a brief case report, the paper should be submitted as a Commentary. All letters should begin with the salutation "Dear Sir."

Caution regarding the use of statistics

General approach – Presentation of results from inferential statistical testing should include sufficient information such as test statistic (t, F, Χ2, etc.) and degrees of freedom (df) accompanying the p-value to document the appropriateness of the analyses. An example of results of an independent sample t-test comparison of an outcome in two groups would be (p=<0.001; t=12.5, df=50). It is also acceptable, particularly when reporting of the test statistic and df is not straightforward (as occurs in some regression modeling situations) to simply identify the inferential procedure and relevant additional information associated with the reported p-value, e.g., (p<0.001; timeXtreatment interaction, mixed effects model). All statistical procedures should be described with sufficient detail in the methods section and identified in the footnotes of tables and figures.

Repeated observations in the same subject – The nature of therapeutic brain stimulation is such that patients usually receive multiple, repeated treatment sessions over a specified period of time. Our statisticians on our editorial board have noted several common mistakes in the conduct and reporting of statistics, particularly in relation to inferential statistical tests performed on repeated observation in the same patient. Depression scores, seizure duration scores, vital signs, etc. from serial treatments within the same patient are assumed to be intercorrelated within that patient, and hence violate the usual assumptions of independence of observations required for most statistical tests involving between group comparisons. For example, 10 individuals each having 3 measurements of HRSD scores over time (sessions) does not result in a sample size of 30 independent HRSD scores for this group. For study designs involving repeated measures within individuals, a statistical method that takes into account the repeated measures must be used.

Small negative studies – Ideally, before any comparative trial is initiated, a valid power analysis is carried out and a sample size having sufficient power to detect a pre-specified clinically important effect is determined. However, occasionally studies are undertaken in which no a priori sample size determination was made (and only available patients were used) or the pre-determined sample size is not achieved. For either of these cases in which a negative (non-statistically significant) result is obtained for the primary outcome variable(s), a post hoc power analysis should be carried out. If this analysis indicates power less than 80%, the results must be presented as a small descriptive and/or pilot study (and reflected in the title of the paper) rather than a confirmatory comparative study involving inferential statistical procedures. Specifically, as a small descriptive and/or pilot study, comparative results should be presented in terms of descriptive measures such as intervention effect sizes (e.g. difference in treatment means or response proportions) accompanied by appropriate confidence intervals on these differences. In the pilot study context, feasibility measures such as study refusal and dropout proportions and estimates of variances for outcome variables are relevant outcome variables and provide useful input information in the event the small study is replicated in a larger, adequately-powered sample. When a study lacks power to detect clinical important intervention group differences, the negative study results (non-significant intervention differences) produced by the inferential statistical procedures must be interpreted as “study findings are inconclusive” or more harshly as a “failed trial.” This is because the failure to detect intervention group differences for the primary outcome(s) may be due to the fact that (a) the relevant clinically important differences do not exist in the population to which inferences are being made or (b) the statistical test simply did not have sufficient power to detect the specified important population differences that actually exist. To be able to conclude (a) above, we must be assured that power was adequate to have found the relevant difference if it exists in the population of inference [i.e. that (b) is not the explanation for the negative finding]. When power is known to be low, the second option prevails for negative findings. For this reason, simple descriptive measures rather than inferential statistical procedures (with their accompanying p-values) should be reported for the small negative trials published in JECT. Note that regardless of power, if statistically significant differences are found for the primary outcome(s), the study qualifies for consideration for publication as a confirmatory comparative study. For this case, negative results for secondary outcomes produced using inferential methods must be interpreted as described above.

Preparation of Manuscript

Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.

Manuscripts must be double-spaced and include continuous line numbering throughout.

Title page: Include on the title page (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) a conflict of interest disclosure statement (see the “Conflicts of Interest” section above) including any sources of support that require acknowledgment. This includes disclosure of funding received for the work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s). If there are no potential conflicts of interest to disclose, please include a statement to that effect.

Structured abstract and key words: Limit the abstract to 250 words. Do not cite references in the abstract. Limit the use of abbreviations and acronyms. Use the following subheads: Objectives, Methods, Results, and Conclusions. List three to five key words.

Unstructured abstract and key words: Limit the abstract to 250 words. It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (e.g., “the significance of the results is discussed”). List three to five key words or phrases.

Text: Organize the manuscript into four main headings: Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer’s name and address (city and state/country). Acknowledge all forms of support, including pharmaceutical and industry support, on the title page of the manuscript.

Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.

Technical Parameters of ECT devices and other brain stimulation devices: Authors should routinely report the make and model of brain stimulation devices, along with the location of the manufacturer. Where relevant , stimulus waveform, stimulus intensity, electrode placement, and seizure duration should be reported. The stimulus waveform, stimulus intensity, electrode placement, and seizure duration monitoring details for ECT should follow the suggestions of "Reporting of Technical Parameters in ECT Publications: Recommendations for Authors," by R. D. Weiner, L. A. Weaver, Jr., and H. A. Sackeim, Convulsive Ther 1988;4:88-91. Copies of the recommendations are available from the Editorial Office.

References: The authors are responsible for the accuracy of the references. Cite the references in the text in the order of appearance using superscripts. Include a double-spaced referenced list, at the end of the manuscript, listing references in order of appearance. Cite unpublished data—such as papers submitted but not yet accepted for publication and personal communications, including e-mail communications—in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:

Journal article

1. Farkas LG, Tompson B, Phillips JH, et al. Comparison of anthropometric and cephalometric measurements of the adult face. J Craniofacial Surg. 1999;10:18-25.

Book chapter

2. Todd VR. Visual information analysis: frame of reference for visual perception. In: Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric Occupational Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; 1999:205-256.

Entire book

3. Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial Fixation. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.

Software

4. Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease Control and Prevention; 1994.

Online journals

5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.

Database

6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.

World Wide Web

7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.

Figures:

A) Creating Digital Artwork

Learn about the publication requirements for Digital Artwork: http://links.lww.com/ES/A42

Create, Scan and Save your artwork and compare your final figure to the Digital Artwork Guideline Checklist (below).

Upload each figure to Editorial Manager in conjunction with your manuscript text and tables.

B) Digital Artwork Guideline Checklist

Here are the basics to have in place before submitting your digital art:

Artwork should be saved as TIFF, PDF, Word Doc, PPT, or EPS files.

Artwork is created as the actual size (or slightly larger) it will appear in the journal. (To get an idea of the size images should be when they print, study a copy of the journal to which you wish to submit. Measure the artwork typically shown and scale your image to match.)

Crop out any white or black space surrounding the image.

Diagrams, drawings, graphs, and other line art must be vector or saved at a resolution of at least 1200 dpi. If the art is created in an MS Office program, convert to a hi-res PDF. If the PDF creation process is unfamiliar then submit the MS Office doc.

Photographs, radiographs and other halftone images must be saved at a resolution of at least 300 dpi.

Photographs and radiographs with text must be saved as postscript or at a resolution of at least 600 dpi.

Each figure must be saved and submitted as a separate file. Figures should not be embedded in the manuscript text file.

Remember:

Cite figures consecutively in your manuscript.

Number figures in the figure legend in the order in which they are discussed.

Upload figures consecutively to the Editorial Manager web site and number figures consecutively in the Description box during upload.

Figure legends: Include legends for all figures. They should be brief and specific, and they should appear after the text and before the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.

Color figures: The journal accepts for publication color figures that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.

Tables: Create tables using the table creating and editing feature of your word processing software (e.g., Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Do not submit tables as image files (e.g., TIFF, JPG, EPS). Submit each table in a separate file. Cite tables consecutively in the text, and number them in that order. Each table should appear on a separate sheet and should include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.

Style: In general, style should be patterned after the American Medical Association Manual of Style (9th edition). Stedman’s Medical Dictionary (27th edition) and Merriam Webster’s Collegiate Dictionary (10th edition) should be used as standard references. Drugs and therapeutic agents should be referred to by their accepted generic or chemical names. The name should not be abbreviated. Code numbers should be used only when a generic name is not yet available. In that case, the chemical name and a figure giving the chemical structure of the drug is required. Copyright or trade names of drugs should be capitalized and placed in parentheses after the name of the drug. Names and locations (city and state in USA; city and country outside USA) of manufacturers of drugs, supplies, or equipment cited in a manuscript are required to comply with trademark law and should be provided in parentheses. Units of measure should be expressed in the metric system, and temperatures should be expressed in degrees Celsius. Conventional units should be written as SI units as appropriate.

Supplemental Digital Content

Supplemental Digital Content (SDC): Authors may submit SDC via Editorial Manager to LWW journals that enhance their article’s text to be considered for online posting. SDC may include standard media such as text documents, graphs, audio, video, etc. On the Attach Files page of the submission process, please select Supplemental Audio, Video, or Data for your uploaded file as the Submission Item. If an article with SDC is accepted, our production staff will create a URL with the SDC file. The URL will be placed in the call-out within the article. SDC files are not copy-edited by LWW staff, they will be presented digitally as submitted. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.

SDC Call-outs

Supplemental Digital Content must be cited consecutively in the text of the submitted manuscript. Citations should include the type of material submitted (Audio, Figure, Table, etc.), be clearly labeled as “Supplemental Digital Content,” include the sequential list number, and provide a description of the supplemental content. All descriptive text should be included in the call-out as it will not appear elsewhere in the article.

Example:

We performed many tests on the degrees of flexibility in the elbow (see Video, Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our results inconclusive.

List of Supplemental Digital Content

A listing of Supplemental Digital Content must be submitted at the end of the manuscript file. Include the SDC number and file type of the Supplemental Digital Content. This text will be removed by our production staff and not be published.

Example:

Supplemental Digital Content 1.wmv

SDC File Requirements

All acceptable file types are permissible up to 10 MBs. For audio or video files greater than 10 MBs, authors should first query the journal office for approval. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.

After Acceptance

Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (e.g., reprint order form) will be sent to the corresponding author by e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected page proofs to the publisher. Those authors without an e-mail address will receive traditional page proofs. It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors’ meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.

Reprints: Authors will receive a reprint order form and a price list with their page proofs. Reprint requests should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears.

Publisher’s contact:

Editorial Coordinator

The Journal of ECT

351 W. Camden St.

Baltimore, MD 21201-2436

Editorial Office Contact:

Emily Hurd

Editorial Coordinator

Wolters Kluwer

Health Learning, Research & Practice

Two Commerce Square

2001 Market Street

Philadelphia, PA 19103

Email: emily.hurd@wolterskluwer.com